Insider filing · TNGX
Adam Crystal
President, R&D
profile →
Tango Therapeutics, Inc.
TNGX · Healthcare · 23 filings in 24 months
ticker →
Adam Crystal sold $572K of Tango Therapeutics (TNGX)
Executed Apr 1, disclosed Apr 2, 1 day later.
Value, as filed
$572K
27,000 sh × $21.20
Executed
Apr 1
the trade date, as filed
Disclosed
Apr 2
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ACAdam Crystal (President, R&D) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $962K of TNGX (38,460 sh × $25.00, as filed), executed Apr 15.
The name
TNGXHealthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adam Crystal in TNGX
TNGXSALE
Tango Therapeutics, Inc.
$604K27,000 sh × $22.37
Exec Sep 1
Filed Sep 3 · 4:01 PM ET TNGXSALE Tango Therapeutics, Inc. $736K
27,000 sh across 2 lots
Exec Aug 3
Filed Aug 5 · 4:01 PM ET TNGXSALE Tango Therapeutics, Inc. $799K
27,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 7:23 PM ET TNGXSALE Tango Therapeutics, Inc. $618K
27,000 sh across 2 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $549K
25,900 sh × $21.19
Exec May 1
Filed May 5 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $962K
38,460 sh × $25.00
Exec Apr 15
Filed Apr 16 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $241K
12,000 sh × $20.11
Exec Mar 25
Filed Mar 27 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $304K
20,251 sh × $15.00
Exec Mar 5
Filed Mar 9 · 5:30 PM ET